Integral Derivatives’s Merck MRK Stock Holding History

Integral Derivatives’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1.78M	Buy	34,165 +2,830	+9%	+$153K	0.04%	134
2017 Q4	$1.68M	Sell	31,335 -3,983	-11%	-$221K	0.03%	336
2017 Q3	$2.16M	Buy	35,318 +11,424	+48%	+$693K	0.04%	293
2017 Q2	$1.46M	Sell	23,894 -23,371	-49%	-$1.42M	0.03%	383
2017 Q1	$2.87M	Sell	47,265 -13,309	-22%	-$807K	0.05%	232
2016 Q4	$3.4M	Buy	60,574 +8,488	+16%	+$497K	0.06%	199
2016 Q3	$3.1M	Buy	52,086 +15,825	+44%	+$925K	0.06%	182
2016 Q2	$1.99M	Buy	36,261 +14,253	+65%	+$759K	0.05%	240
2016 Q1	$1.11M	Sell	22,008 -3,039	-12%	-$149K	0.04%	355
2015 Q4	$1.26M	Buy	25,047 +9,537	+61%	+$481K	0.03%	390
2015 Q3	$731K	Sell	15,510 -7,756	-33%	-$412K	0.02%	605
2015 Q2	$1.26M	Sell	23,266 -2,934	-11%	-$165K	0.03%	448
2015 Q1	$1.44M	Sell	26,200 -9,222	-26%	-$522K	0.03%	394
2014 Q4	$1.92M	Sell	35,422 -42,968	-55%	-$2.39M	0.03%	451
2014 Q3	$4.43M	Buy	78,390 +3,458	+5%	+$194K	0.08%	221
2014 Q2	$4.14M	Buy	74,932 +59,212	+377%	+$3.23M	0.07%	215
2014 Q1	$852K	Buy	15,720 +8,384	+114%	+$434K	0.02%	714
2013 Q4	$350K	Buy	+7,336	New	+$335K	﹤0.01%	1172

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Integral Derivatives's MRK Position: Q1 2018 in Review

Integral Derivatives opened a new position in Merck (MRK) in Q1 2018: 15,785 shares worth $820K. The stake represents 0.02% of the portfolio and ranks #289 among its holdings. This is a return to the name: Integral Derivatives previously reported a position in MRK as recently as Q3 2017.

Integral Derivatives first reported a position in MRK in Q1 2014 and has held it in 12 quarters since. The position peaked at $2.69M in Q2 2014. 1,992 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

Integral Derivatives held 15,785 shares of Merck worth $820K as of Q1 2018.
Merck was a new Integral Derivatives position in Q1 2018.
Merck made up 0.02% of Integral Derivatives's portfolio in Q1 2018, its #289 holding.
Integral Derivatives first reported a position in Merck in Q1 2014 and has held it in 12 quarters since.
Integral Derivatives's Merck position peaked at $2.69M in Q2 2014.
1,992 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.